Aurora Cannabis Inc. (NYSE:ACB – Get Rating) – Jefferies Financial Group issued their Q1 2023 EPS estimates for Aurora Cannabis in a report released on Wednesday, September 28th. Jefferies Financial Group analyst O. Bennett forecasts that the company will earn ($0.08) per share for the quarter. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.33) per share. Jefferies Financial Group also issued estimates for Aurora Cannabis’ Q2 2023 earnings at ($0.07) EPS and Q3 2023 earnings at ($0.06) EPS.
A number of other research analysts also recently issued reports on ACB. Canaccord Genuity Group raised shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research report on Wednesday, September 21st. Piper Sandler decreased their target price on shares of Aurora Cannabis from $4.00 to $3.00 and set a “neutral” rating for the company in a research note on Wednesday, September 21st. Canaccord Genuity Group raised shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a report on Wednesday, September 21st. Stifel Nicolaus raised shares of Aurora Cannabis from a “sell” rating to a “hold” rating and set a $2.15 price objective for the company in a report on Monday, June 6th. Finally, Atb Cap Markets raised shares of Aurora Cannabis from an “underperform” rating to a “sector perform” rating in a research note on Thursday, September 22nd. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $3.76.
Aurora Cannabis Price Performance
Aurora Cannabis stock opened at $1.22 on Friday. Aurora Cannabis has a 12-month low of $1.12 and a 12-month high of $8.69. The firm has a 50-day moving average price of $1.49 and a 200-day moving average price of $2.14. The firm has a market capitalization of $276.69 million, a PE ratio of -0.20 and a beta of 2.64. The company has a current ratio of 5.13, a quick ratio of 4.17 and a debt-to-equity ratio of 0.36.
Hedge Funds Weigh In On Aurora Cannabis
Hedge funds have recently modified their holdings of the business. Exchange Traded Concepts LLC purchased a new position in shares of Aurora Cannabis during the second quarter worth approximately $34,000. City State Bank purchased a new position in Aurora Cannabis in the 4th quarter valued at $40,000. MQS Management LLC purchased a new position in Aurora Cannabis in the 1st quarter valued at $49,000. HighTower Advisors LLC purchased a new position in Aurora Cannabis in the 1st quarter valued at $50,000. Finally, CWM LLC grew its position in Aurora Cannabis by 1,370.0% in the 2nd quarter. CWM LLC now owns 41,776 shares of the company’s stock valued at $55,000 after buying an additional 38,934 shares during the last quarter. 29.53% of the stock is currently owned by hedge funds and other institutional investors.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.
See Also
Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.
Recent Comments